Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

48,000

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

September 30, 2026

Conditions
Cervix CancerCervical Intraepithelial NeoplasiaHuman Papilloma VirusHPV-Related Cervical Carcinoma
Interventions
DEVICE

Colli-Pee Small Volumes

Women will self-collect a first-void urine sample at home upon receipt of the study package using the Colli-Pee Small Volumes (10 mL) device (Novosanis, Belgium). The collector tube is prefilled with a preservative (UCM, Novosanis, Belgium). Women will send the collector vial containing first-void urine along with the informed consent form to the laboratory at University of Antwerp using the prestamped envelope.

DEVICE

Evalyn Brush

Women will self-collect a vaginal sample at home upon receipt of the study package using the Evalyn Brush device (Rovers Medical Devices, The Netherlands). Women will send the used brush along with the informed consent form to the laboratory at University of Antwerp using the prestamped envelope.

Trial Locations (1)

2650

Universiteit Antwerpen, Edegem

All Listed Sponsors
collaborator

Antwerp University Hospital (UZA)

UNKNOWN

collaborator

Centre for Cancer Detection (CvKO)

UNKNOWN

collaborator

Sciensano

OTHER_GOV

lead

Universiteit Antwerpen

OTHER